COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 218.3 | 9 | 0015-0206 | 858.14 | 205.90 | 261 | 62.18 | 0.848 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.9 | 9 | 0016-0210 | 14.17 | 209.59 | 216 | 55.60 | 0.878 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 273.6 | 9 | 0017-0211 | 377.37 | 210.79 | 172 | 54.04 | 0.740 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 287.9 | 9 | 0018-0224 | 388.18 | 223.96 | 199 | 56.53 | 0.783 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.8 | 9 | 0019-0235 | 80.57 | 235.54 | 201 | 56.18 | 0.800 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 288.1 | 9 | 0020-0244 | 687.08 | 243.72 | 274 | 63.36 | 0.858 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 302.6 | 9 | 0021-0246 | 299.45 | 245.54 | 343 | 72.43 | 0.822 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 258.5 | 9 | 0022-0255 | 445.90 | 255.26 | 242 | 57.94 | 0.906 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 309.9 | 9 | 0023-0268 | 478.14 | 267.59 | 245 | 58.77 | 0.891 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 262.9 | 9 | 0024-0306 | 621.04 | 306.21 | 306 | 65.60 | 0.894 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 213.7 | 9 | 0025-0336 | 263.52 | 336.65 | 255 | 77.50 | 0.534 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 220.5 | 9 | 0026-0338 | 565.15 | 337.78 | 294 | 65.60 | 0.859 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 312.9 | 9 | 0027-0352 | 423.01 | 352.32 | 230 | 57.36 | 0.879 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 304.3 | 9 | 0028-0359 | 647.64 | 359.30 | 201 | 52.04 | 0.933 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.7 | 9 | 0029-0366 | 121.04 | 366.56 | 347 | 72.08 | 0.839 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 246.1 | 9 | 0030-0371 | 599.07 | 371.81 | 274 | 62.77 | 0.874 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.3 | 9 | 0031-0392 | 112.90 | 392.27 | 302 | 70.18 | 0.770 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 347.2 | 9 | 0032-0394 | 544.89 | 393.62 | 265 | 87.64 | 0.434 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 246.6 | 9 | 0033-0396 | 427.88 | 397.25 | 206 | 56.77 | 0.803 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 212.7 | 9 | 0034-0412 | 642.60 | 412.11 | 280 | 69.26 | 0.734 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 268.1 | 9 | 0035-0416 | 462.97 | 416.38 | 197 | 60.28 | 0.681 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 260.9 | 9 | 0036-0419 | 369.72 | 418.83 | 238 | 60.53 | 0.816 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 275.0 | 9 | 0037-0428 | 443.00 | 427.25 | 275 | 64.77 | 0.824 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.0 | 9 | 0038-0429 | 515.38 | 429.72 | 271 | 61.70 | 0.895 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 245.6 | 9 | 0039-0440 | 364.69 | 440.16 | 252 | 61.01 | 0.851 |